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and the risk of postoperative delirium in elderly
hip fracture patients
Dunja Westhoff1*†, Joost Witlox2†, Leo Koenderman4, Kees J Kalisvaart5, Jos F M de Jonghe2, Mireille F M van Stijn3,
Alexander P J Houdijk3, Inge C M Hoogland1, Alasdair M J MacLullich8, David J van Westerloo6,
Diederik van de Beek1, Piet Eikelenboom1,7 and Willem A van Gool1Abstract
Background: Aging and neurodegenerative disease predispose to delirium and are both associated with increased
activity of the innate immune system resulting in an imbalance between pro- and anti-inflammatory mediators in
the brain. We examined whether hip fracture patients who develop postoperative delirium have altered levels of
inflammatory mediators in cerebrospinal fluid (CSF) prior to surgery.
Methods: Patients were 75 years and older and admitted for surgical repair of an acute hip fracture. CSF samples
were collected preoperatively. In an exploratory study, we measured 42 cytokines and chemokines by multiplex
analysis. We compared CSF levels between patients with and without postoperative delirium and examined the
association between CSF cytokine levels and delirium severity. Delirium was diagnosed with the Confusion
Assessment Method; severity of delirium was measured with the Delirium Rating Scale Revised-98. Mann–Whitney
U tests or Student t-tests were used for between-group comparisons and the Spearman correlation coefficient was
used for correlation analyses.
Results: Sixty-one patients were included, of whom 23 patients (37.7%) developed postsurgical delirium.
Concentrations of Fms-like tyrosine kinase-3 (P=0.021), Interleukin-1 receptor antagonist (P=0.032) and Interleukin-6
(P=0.005) were significantly lower in patients who developed delirium postoperatively.
Conclusions: Our findings fit the hypothesis that delirium after surgery results from a dysfunctional
neuroinflammatory response: stressing the role of reduced levels of anti-inflammatory mediators in this process.
Trial registration: The Effect of Taurine on Morbidity and Mortality in the Elderly Hip Fracture Patient.
Registration number: NCT00497978. Local ethical protocol number: NL16222.094.07.
Keywords: Delirium, Cytokines, Neuroinflammation, Cerebrospinal fluid, Neurodegeneration, Hip fractureBackground
Delirium, an acute and fluctuating impairment in atten-
tion and cognition, is the most common complication in
hospitalized older people [1]. Delirium is associated with
an increased risk of death, institutionalization, and de-
mentia, independent of important confounders [2]. The
pathophysiological mechanism of delirium is largely* Correspondence: d.westhoff@amc.uva.nl
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reproduction in any medium, provided the orunknown, and a multifactorial etiology has been suggested
[3]. Multiple lines of evidence indicate that a maladaptive
neuroinflammatory response in the brain likely plays an
important role in the development of delirium [4,5]. Sev-
eral precipitating factors for delirium have been described,
such as infection, malnutrition, fractures, and surgery [6].
All of these factors share an increased systemic produc-
tion of cytokines [7,8]. Aging and cognitive impairment
are the major predisposing factors for the development of
delirium, and both have been associated with alteredal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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vous system (CNS), resulting in an imbalance between
pro- and anti-inflammatory cytokines [9]. Through the
different pathways that serve immune-to-brain communi-
cation, a systemic inflammatory response may well lead to
activation of microglia, the innate immune cells of the
CNS. Activated microglia secrete several immune factors,
such as cytokines and chemokines. In the elderly,
microglia show a more reactive phenotype and release
increased quantities of cytokines in the brain after per-
ipheral stimulation [9]. This microglial response may be
less well-regulated due to reduced cholinergic feedback
in older persons, mediating the detrimental effects on
prognosis [10].
Elderly patients with hip fracture are especially vulner-
able, since the fracture itself and subsequent surgery are
two events leading to a systemic response [11]. So far,
no association has been shown between preoperatively
measured pro-inflammatory cytokines in serum and the
incidence of delirium after hip surgery in hospitalized
elderly [12-14]. In contrast, one study did find a signifi-
cant association between lower levels of the circulating
anti-inflammatory cytokine Interleukin-1 receptor antag-
onist (IL-1ra) and delirium [13]. This might suggest that
delirium is perhaps not so much the result of an in-
creased pro-inflammatory state, but rather a conse-
quence of reduced anti-inflammatory activity.
In this exploratory study, we hypothesized that elderly
hip fracture patients with altered CNS cytokine profiles be-
fore surgery, indicating either increased pro-inflammatory
or reduced anti-inflammatory activity, are specifically at
risk for developing delirium postoperatively. We studied
this hypothesis by analyzing a range of pro- and anti-
inflammatory markers in cerebrospinal fluid (CSF) in eld-
erly patients undergoing emergency hip surgery.
Methods
Ethical consideration
Was conducted in accordance with the guidelines of
Good Clinical Practice. All patients gave written in-
formed consent.
Patients and clinical outcomes
Patients were participants in a double blind randomized
study comparing effectiveness of taurine versus placebo in
reducing morbidity and 1-year mortality in elderly hip
fracture patients. During 1 year, all patients of 75 years or
older who were admitted for surgical repair of a hip frac-
ture in a teaching hospital in Alkmaar, the Netherlands,
were checked for eligibility. Patients were excluded if they
had no acute trauma, received total hip prosthesis, had a
pathological fracture, were not willing or not capable (for
example, dementia, aphasia, coma) to provide consent, or
had contraindications regarding the administration oftaurine (that is, renal failure defined as a creatinine clear-
ing <30 mL/min). Written informed consent was obtained
after eligibility was checked and the patient had been in-
formed. Since all participants were at high risk of delirium
(75 years or older, acute hospital admission), patients re-
ceived routine care with prophylactic treatment of 0.5 mg
haloperidol, three times daily from admission until post-
operative day 3, unless contraindications were present
[15]. Baseline assessment was completed within 12 h after
submission, before surgery, including assessments of cog-
nitive functioning, visual impairment, severity of acute ill-
ness, depression, activities of daily living, and risk factors,
presence and severity of delirium as reported previously in
more detail [2,16]. Medical records were inspected and
patients and proxies were interviewed on prefracture
functioning and demographic factors, including home
situation and low or high educational level. Blood was
drawn preoperatively to assess C-reactive protein (CRP),
erythrocyte sedimentation rate (ESR) and IL-6 as a meas-
ure of systemic inflammation.
The main outcome was postoperative delirium, de-
fined according to the Confusion Assessment Method
(CAM) [17]. Presence and severity of delirium were
assessed daily until the fifth postoperative day. Delirium
severity was measured using the Delirium Rating Scale
Revised-98 (DRS-R-98) [18]. In case of a positive CAM
score, assessments were continued at least until the
CAM was negative for 3 consecutive days or discharge.
Severity of postoperative delirium was defined as the
highest DRS-R-98 score.
Cerebrospinal fluid samples and chemo- and cytokines
CSF samples were collected during canulation for the
introduction of spinal anesthesia, prior to administration
of any anesthetic. Lumbar punctures were performed
with a 25-gauge needle between the L3-L4 or L4-L5
intervertebral space. A withdrawal protocol was used to
standardize the handling of the CSF samples. In each pa-
tient 13 mL of CSF was collected in polypropylene tubes
which were transported to the laboratory within 15 min
after withdrawal. No later than 15 min after arrival at
the laboratory the CSF samples were centrifuged at
1,800 g for 10 min at 4°C and aliquoted into polypropyl-
ene tubes that were stored at −20°C. The next day sam-
ples were transferred to −80°C.
To assess cytokine and chemokine levels, we used
Luminex® technology: the Human Cytokine and Chemo-
kine Panel, a premixed multiplex analysis (Milliplex,
Millipore, Billerica, MA, USA). Based on previous experi-
ence with this assay, CSF samples were diluted 10 times.
We determined 42 cytokines and chemokines: epidermal
growth factor (EGF), eotaxin, fibroblast growth factor 2
(FGF-2), FMS-like tyrosine kinase 3 ligand (Flt-3L),
Fractalkine, granulocyte colony stimulating factor (G-CSF),
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CSF), growth-regulated oncogene (GRO), Interferon (IFN)
α2, IFN-γ, IL-1ra, IL-1α, IL-1β, IL-2, soluble IL-2 Receptor
alpha (sIL-2Ra), IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9,
IL-10, IL-12p40, IL-12p70, IL-13, IL-15, IL-17, Interferon
gamma-induced protein 10 (IP-10), monocyte chemotactic
proteins-1 and 3 (MCP-1, MCP-3), macrophage-derived
chemokine (MDC), macrophage inflammatory proteins 1α
and 1β (MIP-1α, MIP-1β), platelet-derived growth factors
AA and AB/BB (PDGF-AA, PDGF-AB/BB), regulated and
normal T-cell expressed and secreted (RANTES), solubleTotal number of patients with hip fracture 
March 2008 – March 2009 
N = 257
Number in trial
N = 122
Number with CSF sample
N = 78
Number analyzed
N = 61
Figure 1 Flowchart of study inclusion.CD40 ligand (sCD40L), transforming growth factor α
(TGF-α), tumor necrosis factors α and β (TNF-α and β),
and vascular endothelial growth factor (VEGF).
Analysis
We first compared preoperative CSF cytokine levels and
baseline risk factors between patients with or without
postoperative delirium. Next we also investigated the as-
sociation between preoperative CSF cytokine levels and
delirium severity. Statistics were performed using SPSS
(SPSS for Windows, version 20, IBM Corporation,Number excluded N = 135
- Not able (dementia, aphasia, coma) N=64
- Not willing N=20
- Renal failure N=20
- No surgery or transfer to other hospital N=13
- No acute trauma, total hip prosthesis,  
pathological fracture N=11
- Missed N=4
- Language barrier N=3
Number excluded N = 44
- General anaesthesia N=26
- NoCSF collected N=18
Number excluded N = 17
- Preoperative delirium N=3
- No postoperative delirium assessments N=1
- Steroids and/or NSAIDs N=6
- Unclear labelling of sample N=7
Table 1 Baseline characteristics of patients with and
without postoperative delirium
No delirium Delirium P
valuen=38 (62%) n=23 (38%)
Age (years) 82.9 ±4.5 84.6 ±5.2 0.18
Gender n/N (% female) 26/38 (68.4) 16/23 (69.9) 0.93
Living independently, n/N (%) 25/38 (65.8) 15/23 (65.2) 0.68
Low educational level, n/N (%) 13/36 (36.1) 7/22 (31.8) 0.78
Visual impairmenta, n/N (%) 2/38 (5.3) 1/21 (4.8) 0.93
APACHE IIb score 13 (11–13) 13 (12–14) 0.20
ASAc group, n/N (%) 0.04
Group I; 17/38 (44.7) 4/23 (17.4)
II; 17/38 (44.7) 12/23 (52.2)
III; 4/38 (10.5) 7/23 (30.4)
Number of co-morbid diseases 1.0 (1.0-2.0) 2.0 (1.0-2.0) 0.26
Number of medications
at home
2.5 (1.0-5.0) 4.0 (3.0-5.0) 0.06
IQCODE-Nd score 3.2 (3.0-3.4) 3.8 (3.3-4.1) <0.001
IQCODE-Nd score >3.6, n/N (%) 4/37 (10.8) 13/21 (61.9) <0.001
MMSEe score 25.6 ±2.5 23.2 ±3.6 0.005
MMSEe score <24, n/N (%) 8/37 (21.6) 11/22 (50.0) 0.04
GDSf score 2.0 (1.0-3.0) 2.0 (1.0-3.0) 0.96
BIg score 19.0 (17.9-20.0) 18.0 (14.8-20.0) 0.03
Lawton IADLh score 10.0 (8.0-14.7) 14.5 (11.3-17.8) 0.03
Values are expressed as means ± SD or median (IQR), n/N is number with
characteristic/total number, (%) is percentage.
aVisual impairment measured with the standardized Snellen test for visual
impairment and defined as binocular near vision worse than 20/70 after correction.
bAPACHE II: Acute Physiological and Chronic Health Evaluation II, range 0
(no acute health problems) to 70 (severe acute health problems).
cASA: American Society of Anesthesiologists physical status classification
system, range 1 (normal health) to 5 (moribund).
dIQCODE-N: Informant Questionnaire on Cognitive Decline in the Elderly -
Short Form, range 16 (cognitive improvement) to 80 (severe cognitive decline),
mean score >3.6 indicates cognitive decline.
eMMSE: Mini Mental State Examination, range 0 (severe cognitive impairment)
to 30 (no cognitive impairment), score <24 indicates cognitive impairment.
fGDS: Geriatric Depression Scale, range 0 (depression not likely) to 15
(depression very likely).
gBI: Barthel Index of Activities of Daily Living, range 0 (severe disability) to 20
(no disability).
hLawton IADL: Lawton Instrumental Activities of Daily Living scale, range 8 (no
disability) to 31 (severe disability).
Table 2 Preoperative serum biomarker levels of patients
with and without postoperative delirium
Biomarker No delirium Delirium P value
Median (IQR) Median (IQR)
IL-6 23.16 (9.51-44.10) 48.13 (24.85-55.74) 0.021
N=37 N=23
CRP* 3.00 (1.00-6.50) 4.00 (1.00-8.00) 0.354
N=17 N=14
ESR# 14.00 (8.00-23.50) 15.00 (7.00-23.00) 0.589
N=37 N=23
*CRP, C-reactive protein; #ESR, erythrocyte sedimentation rate.
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ware, version 5.01, La Jolla, CA, USA). Quantitative vari-
ables are presented as mean with standard deviation
(SD) or median with interquartile range (IQR). Categor-
ical variables were analyzed using Chi-Square or Fisher
Exact tests. Continuous variables were tested with Mann–
Whitney U tests or Student t-tests depending on sample
size and distribution of the data. The assumption of
normality was tested with the Kolmogrov-Smirnov test.
Since cytokine data were significantly skewed, Mann–
Whitney U tests were employed. Spearman’s correlation
was used for correlation analysis. Statistical significance
was set to P ≤0.05. Because of the exploratory nature of
this study, correction for multiple comparisons was not
applied.
Results
From March 2008 to March 2009, 122 of 257 hip frac-
ture patients fulfilled criteria for participation and pro-
vided consent (Figure 1). Of these 122 patients, 26
patients received general anesthesia and in 18 patients
CSF collection could not be performed due to logistical
limitations. Subsequently, 17 additional patients were ex-
cluded: samples were not labeled clearly (n=7), use of
steroids and/or non-steroidal anti-inflammatory drugs
(NSAIDs) (n=6), preoperative delirium (n=3), no postop-
erative delirium assessment (n=1), leaving 61 patients
for analysis in this exploratory study. Twenty-three of
these 61 patients (37.7%) developed postsurgical delir-
ium. Median time of delirium onset after operation was
1 day (IQR 1.0-2.0), and 20 patients (87%) developed de-
lirium within 2 days of surgery.
The characteristics of patients with and without post-
operative delirium are shown in Table 1. Patients who
developed delirium showed more signs of cognitive im-
pairment, both immediately preoperative (MMSE) and
before hospital admission (IQCODE-N). Additionally,
these patients were more dependent on caregivers with
regard to the activities of daily living (ADL) and instru-
mental ADL (IADL) functioning. Furthermore, patients
who developed postoperative delirium were more se-
verely ill prior to surgery as measured with the Ameri-
can Society for Anesthesiology classification system.
With the exception of serum urea and creatinine levels
[19], other baseline variables including serum parame-
ters of liver function, renal clearance, creatine kinase,
hemoglobin concentration, and white blood cell count
between patients who did or did not develop postopera-
tive delirium were similar (data not shown). Serum levels
of CRP and ESR between patients with and without
postoperative delirium were similar (P=0.354 and
P=0.589, Table 2). Preoperative serum IL-6 was signifi-
cantly higher in patients with postsurgical delirium
(P=0.021).
Table 4 Preoperative CSF cytokine levels of patients with
and without postoperative delirium
Cytokine/
chemokine
Concentration (pg/mL) P value
No delirium (N=38) Delirium (N=23)
Median (IQR) Median (IQR)
Flt-3L 20.16 (18.2-29.5) 16,54 (12.2-20.2) 0.021
G-CSF 31.26 (14.7-55.8) 23.15 (14.7-33.9) 0.233
IFN-α2 31.70 (21.1-41.1) 24.41 (17.7-34.1) 0.136
IFN-γ 1.61 (1.6-2.4) 1.61 (1.6-2.4) 0.336
IL-1α 0.28 (0.2-2.3) 0.78 (0.1-1.3) 0.170
IL-1ra 6.90 (2.9-6.9) 2.90 (2.9-6.9) 0.032
IL-6 0.99 (0.2-2.2) 0.21 (0.1-0.7) 0.005
IL-8 28.40 (22.7-42.5) 25.25 (19.4-37.6) 0.308
IL-15 3.47 (1.4-4.5) 2.79 (1.4-3.5) 0.060
IP-10 270.84 (183.1-350.6) 334.21 (241.0-590.0) 0.064
MCP-1 312.67 (257.2-422.6) 301.79 (241.6-389.5) 0.634
MCP-3 19.4 (12.2-25.2) 19.4 (19.4-25.2) 0.375
PDGF-AA 8.04 (5.6-10.3) 6.67 (5.4-9.0) 0.267
RANTES 3.50 (0.1-3.5) 0.08 (0.1-3.5) 0.290
sCD40-L 1.14 (0.06-1.1) 0.06 (0.06-1.1) 0.263
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were below limit of detection in all samples. EGF, FGF2,
Fractalkine, GM-CSF, GRO, IL-1β, IL-2, IL-3, IL-4, IL-5,
IL-7, IL-9, IL-10, IL-12p70, IL-13, IL-17, MDC, PDGF-
AB/BB, sIL-2ra, TNF-α, and TNF-β were detectable in
CSF of <50% of patients only. Patients who developed
postoperative delirium were less likely to have detectable
levels of IL-3 (44.7% vs. 17.4%, P=0.05). Except for IL-3,
no differences were found in detectability of cytokines
per group (Table 3). Because of these limited numbers
and the resulting reduced power, no further analyses
were performed on these variables.
Preoperative CSF concentrations of cytokines that were
measurable in at least 50% of all samples are presented in
Table 4. Concentrations of Flt-3L (P=0.021), IL-1ra
(P=0.032), and IL-6 (P=0.005) were significantly lower in
patients who developed delirium postoperatively. Concen-
trations of IL-15 were lower (P=0.060) and IP-10 were
higher (P=0.064) in the patients who developed delirium
compared to those who did not develop delirium, though
these differences did not reach statistical significance.
Restricting our comparisons with controls to only those
patients who developed delirium shortly after surgeryTable 3 Number of patients with detectable preoperative
CSF cytokine concentrations
Cytokine/
chemokine
No delirium (N=38) Delirium (N=23) P value
n (%) n (%)
EGF 4 (10.5) 7 (30.4) 0.083
FGF-2 4 (10.5) 3 (13.0) 1
Fractalkine 8 (21.0) 7 (30.4) 0.541
GM-CSF 2 (5.3) 1 (4.3) 1
GRO 2 (5.3) 0 - 0.522
IL-1β 1 (2.6) 1 (4.3) 1
IL-2 3 (7.9) 4 (17.4) 0.409
IL-3 17 (44.7) 4 (17.4) 0.050
IL-4 11 (28.9) 3 (13.0) 0.214
IL-5 15 (39.5) 6 (26.1) 0.406
IL-7 14 (36.8) 5 (21.7) 0.264
IL-9 1 (2.6) 0 - 1
IL-10 7 (18.4) 2 (8.7) 0.462
IL-12p70 1 (2.6) 1 (4.3) 1
IL-13 15 (39.5) 7 (30.4) 0.586
IL-17 1 (2.6) 0 - 1
MDC 8 (21.0) 3 (13.0) 0.510
PDGF-AB/BB 1 (2.6) 0 - 1
sIL-2Ra 7 (18.4) 4 (17.4) 1
TNF-α 12 (31.6) 7 (30.4) 1
TNF-β 4 (10.5) 3 (13.0) 1
MDC 8 (21.0) 3 (13.0) 0.510
TGF-α 1.99 (1.4-3.2) 1.99 (1.4-2.6) 0.411(<48 h) generally did not affect any of the findings
mentioned above. Concentrations of CSF cytokines
were not related to treatment allocation in taurine of
placebo groups.
We explored the relationship between age, cognitive
function, and CSF cytokine variables. No significant corre-
lations were found between age, baseline cognitive function
(MMSE), pre-existent cognitive impairment (IQCODE-N),
and levels of CSF cytokines. Stratification of the MMSE
and IQCODE-N according to the abovementioned cutoff
scores did not reveal different outcomes (data not shown).
As levels of cytokines tend to fluctuate over time we inves-
tigated if time from admission to surgery influenced CSF
cytokine levels. Mean time from admission to surgery was
19 h (SD ± 10.0). The time between admission and surgery
was not associated with levels of CSF cytokines or their ra-
tios. In contrast, both the incidence (P=0.05) and the sever-
ity (Spearman’s rho= 0.32, P=0.009) of postoperative
delirium were influenced by the time patients waited for
hip surgery.
Discussion
We explored the association between the occurrence of
postoperative delirium and preoperative cytokine and che-
mokine levels in the CSF. Despite the limited power of
this exploratory study, we found significantly lower levels
of Flt-3L, IL-1ra, and IL-6 and distinct trends for lower
levels of IL-15 and higher levels of IP-10 in CSF of pa-
tients with postoperative delirium. Although the nature of
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consistent with the hypothesis that delirium after surgery
results of neuroinflammatory changes [4,10,20].
IL-1ra is an inhibitor of the pro-inflammatory cyto-
kines IL-1β and IL-1α and is naturally present in the
brain [21]. Reduced CSF levels of this inhibitor are
therefore associated with an increased inflammatory
state of the CNS. This is illustrated by the fact that intra-
thecal levels of IL-1ra are significantly lower in patients
with Alzheimer’s disease (AD) [22] and in patients with
peripheral inflammatory diseases such as rheumatic
arthritis [23], similar to the patients who developed de-
lirium in the current study.
Flt-3L is an early acting cytokine that potently stim-
ulates the proliferation, differentiation and mobilization
of hematopoietic precursor cells into macrophages, os-
teoclasts, microglial, and dendritic cells [24,25]. The
dendritic cell represents a cellular component of an
immune circuit between the brain immune system and
the periphery [26]. The introduction of adenovirus ex-
pressing Flt3L in animals enhanced the formation of
dendritic cells [27], while inhibition of the Flt3 recep-
tor in an experimental mouse model of MS led to
apoptosis of dendritic cells and aggravation of symp-
toms [28]. In the healthy brain, the Flt-3 receptor is
highly expressed in neurons of the hippocampus and
cerebellum [29], while Flt-3Ligand is abundantly
expressed in the pyramidal cells of the hippocampus
[29], an area important for memory and spatial navigation.
In CSF of AD patients, low levels of Flt-3L have been ob-
served [30]. Lower levels of Flt-3L thus may play a role in
the increased susceptibility to infection [31] and chronic
inflammatory states [32] in older persons [33], and in cog-
nitive decline.
The trend towards preoperatively increased IP-10 con-
centration in patients who developed delirium postoper-
atively is interesting since IP-10 plays a pivotal role in
the immune system as an important regulator of the
growth of immature hematopoietic progenitor cells, and
in T-cell migration. IP-10 is secreted by astrocytes and
microglia, and elevations of this chemokine in CSF of
patients with mild cognitive impairment and mild AD
have been described [34]. Immunohistochemically, IP-10
expression is upregulated in AD brain sections com-
pared to controls [35]. In the brain tissue of patients
with HIV-associated dementia, a significant increase in
neuronal cell death was observed when in vitro brain tis-
sue was exposed to IP-10 [36]. The trend towards higher
IP-10 levels in patients with postoperative delirium
suggests a role of this chemokine in an active chronic-
inflammatory process. Taken together, lower levels of IL-
1ra, Flt-3L, and IP10 might reflect a skewing towards a
pro-inflammatory phenotype in the brain contributing to
the development of delirium postoperatively.In this descriptive study it is surprising to find that
lower levels of IL-6 as well as IL-15 were associated with
the development of postoperative delirium.
IL-6 is a critical cytokine connecting innate and ac-
quired immunity, and is vital for induction of both periph-
eral and central defence against injury and inflammation
[37]. It is secreted by immune cells, including microglia,
in response to danger signals. Although IL-6 is often re-
lated to inflammation, it also contributes in the normal
function of the brain [38]. Studies with IL-6 knockout
mice show an important role for IL-6 in sleep-wake be-
havior [39], emotional reactivity [40], sickness behavior
[41], and learning and memory [42]. Furthermore, it is im-
portant for adult neurogenesis [43] and gliogenesis [44].
IL-6 levels are detectable in the serum of older subjects,
even in the absence of illness or inflammation [45]. This
increase might contribute to the development of frailty
and the predisposition to inflammatory diseases [46].
IL-6 is increased also in amyloid plaques or brain tissue
extract of AD patients [47], suggesting that IL-6 is asso-
ciated with an increased neuroinflammatory state in
AD [48]. Amyloid-β (Aβ) induces massive gliosis and trig-
gers IL-6 production. However, in vivo studies with AD
transgenic mouse models suggest a protective role of IL-6,
since it can induce differentiation of microglia into phago-
cytic macrophages capable of degrading Aβ [49,50]. Al-
though IL-6 seems to be overexpressed in brains of AD
patients, limited observational data suggest that IL-6 levels
are not increased in the CSF of AD patients [34,51]. In pa-
tients with delirium, like Alzheimer’s patients, blood and
brain IL-6 are higher compared to controls [52-54]. We
found that patients with postoperative delirium have
higher levels of serum IL-6, which is conform the systemic
inflammatory hypothesis of delirium. Higher IL-6 levels in
preoperative serum in association with postoperative delir-
ium, in the absence of such a relation in CSF, is difficult to
explain. One can speculate that increased serum IL-6
levels may be an early manifestation of an increased in-
flammatory reaction in patients prone to develop delirium
24 h later on average. A previous study, in which rats were
subject to femur fracture, showed elevated systemic cyto-
kines 24 h after injury while brain cytokines did not differ
from controls [55]. Increased systemic, serum cytokine
levels may precede an increased neuroinflammatory re-
sponse associated with delirium.
The trend of lower CSF levels of IL-15 is difficult to
interpret. IL-15 is a cytokine that is produced by astro-
cytes and microglia in response to danger signals such
as toxins and pro-inflammatory cytokines [56]. It actively
modulates microglial reactivity, controlling additional
cytokine, and chemokine release [57], but no consensus
has been reached about the clinical consequences of this
modulation [58]. Follow-up studies should focus on in-
vestigating the role of these two cytokines as the current
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ferences observed with regard to IL-6 and IL-15.
Previous studies have shown that in elderly hip frac-
ture patients, blood levels of inflammatory cytokines are
associated with delirium [12-14]. However, these studies
included both delirious and non-delirious patients at the
time of sampling, or evaluated the postoperative time-
course of cytokines in delirium and controls. Two stud-
ies did measure preoperative cytokines in non-delirious
patients. In one study, in mainly healthy older people
undergoing elective hip replacement [12], the absence of
differences in serum cytokines between patients with
and without postoperative delirium, can be taken to re-
flect the absence of acute illness. The second study only
included acutely ill older persons, and found that low
serum levels of neuroprotective factors IGF-I and IL-1ra
were associated with delirium [13]. One earlier prelimin-
ary study examined CSF cytokines in hip fracture pat-
ents, and showed higher preoperative IL-8 levels in hip
fracture patients with delirium as compared to non-
delirious controls [59]. However, this study included pa-
tients with pre- and postoperative delirium at the time
of CSF collection, and thus could not determine whether
higher CSF IL-8 should be regarded as a ‘risk factor’ for
delirium or as a ‘marker’ of delirium. Our findings are
based on a larger sample of patients all without delirium
at the time of CSF sampling.
The present data suggest that delirium is perhaps not the
result of an increased pro-inflammatory state of the CNS,
but rather is caused by an impaired anti-inflammatory re-
sponse. Without these regulatory cytokines, the brain may
be subject to unrestrained neuro-inflammation, which may
clinically manifest itself as delirium. However, the results of
this exploratory study are not sufficiently strong enough to
use the observed cytokine profiles for predicting delirium
in postsurgical elderly. Inflammation is a highly complex
and dynamic process during which many different cyto-
kines and numerous other effectors interact. The state of
inflammation is thus not likely to be dependent on the net
effect of individual cytokines only, but on the balance be-
tween pro- and anti-inflammatory mediators [9]. Moreover,
inflammatory markers CRP and ESR did not significantly
differ between groups, which is consistent with previous
results [12,14,54]. This finding shows that the systemic in-
flammatory environment does not necessarily reflect in-
flammation in the CNS and vice versa.
Althoughwe employed a sensitivemethod to quantify cy-
tokines [60], levels of 5 cytokines were below the detection
limit, and 21 cytokines were detectable in a minority of pa-
tientsonly.This couldbedue to low levels of these cytokines
in the CSF or perhaps be related to compartmentalization
of cytokines in the brain extracellular space [61], and/or to
their short half-life [62].Mean time between admission and
samplingwas19h.One could argue that cytokine levels thatchanged following fracture, could have normalized in this
time-window.However, several studies show thatCSFcyto-
kine levels remain altered at least for 20 h, possibly even
extending to 96 h after the insult [63,64]. There are several
issues that deserve further comment. We deliberately
choose not to include adjustments for baseline differences
in our exploratory analyses because in doing so the medi-
ating effect of changes in cytokine profiles might be ob-
scured. The question of whether changes in the blood–
brain barrier or specific effects of medication may have
played a role should be addressed in future studies, even
though patients who used steroids and/or NSAIDs prior
to hospital admission were excluded in our analyses. Delir-
ium assessments took place several hours before CSF sam-
ples were collected. Despite close attention of the nursing
staff, during this window, in theory, some patients could
have developed preoperative delirium, and as consequence
may have been falsely classified in the preoperative period.
Time between hip fracture and subsequent surgery poten-
tially represents an important confounder of the associ-
ation between cytokines and postoperative delirium. We
were not able to examine this since we do not have data
on the time period between fracture and hospital admis-
sion. However, we did examine the influence of a related
time period, namely the ‘time between hospital admission
and surgery’. All participants received routine care with
low dose prophylactic haloperidol. Haloperidol has been
reported to reduce both the severity of postoperative delir-
ium [15] and levels of pro-inflammatory cytokines [65].
However, several studies that assessed the influence of
haloperidol on cytokines in schizophrenic patients, did
not find any effect on serum levels of IL-1ra, sIL2R, IL-6,
and TNF-α after 6 weeks of treatment [66]. IL-2 levels did
decrease after 8 weeks of treatment, although the mean
dose in this study was 14.9 mg/day [66,67]. In CSF of
schizophrenic patients, haloperidol treatment did not sig-
nificantly alter levels of IL-6 and IL-2 [68]. One study
examined levels of serum sIL-2r after a haloperidol chal-
lenge of 4 or 10 mg in normal, healthy controls, which
showed no influence on serum levels of sIL-2r [69]. Pa-
tients in our study received much lower doses of haloperi-
dol, 1.5 mg per day. Acute neuroleptic administration
does not seem to influence cytokine levels at these low
doses.
A role for neuroinflammation in the pathophysiology of
delirium may provide new opportunities for clinical inter-
vention. The poor long-term prognosis of delirium in eld-
erly patients [2] and the evidence for prevention over
management of delirium underlines the importance of ad-
equate preventive measures [70]. Interventions that may
ameliorate neuroinflammation could raise the reserve cap-
acity of the brain and thereby the threshold for episodes
of delirium. Controlled studies are necessary to validate a
role of an impaired anti-inflammatory response in the
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and its negative sequelae can be averted by targeting the
neuroinflammatory balance.
Conclusion
Our findings fit the hypothesis that delirium after surgery
results from a dysfunctional neuroinflammatory response:
this may partly be a consequence of reduced levels of anti-
inflammatory mediators rather than exclusively an excess
of pro-inflammatory cytokines. Because the brain is never
exposed to only a single cytokine, future studies should
focus on the balance between multiple pro- and anti-
inflammatory mediators. The influence of the innate im-
mune system in delirium pathophysiology offers scope for
prevention by targeting neuroinflammation.
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